Des Moines Register
By TONY LEYS
The state of Iowa has received $1.9 million from a national pharmaceutical company that was accused of fraud.
Bristol-Myers Squibb agreed last fall to pay a total of $515 million to settle federal and state allegations of misconduct. David Werning, a spokesman for the Iowa Department of Inspections and Appeals, said the state received its share last week.
The allegations included that the New York-based company gave physicians improper incentives to prescribe its drugs, and that it marketed the anti-psychotic drug Abilify for use in children and for people with dementia, even though those uses were not approved.
The company also was accused of overcharging state Medicaid programs for the anti-depression medicine Serzone.